CCNB1 has also been indicated to be an oncogenic factor in the proliferation of HCC cells [9], showing a significant impact on the patient’s survival time [16, 79] and thus has been targeted for cancer treatments [18]. This evidence concerns the gene CCNB1 and hepatocellular carcinoma.